GlaxoSmithKline successfully ended an early trial for a Hepatitis C vaccine, the first time a vaccine candidate for the widespread infection reaches this stage. Hepatitis C is the most common transmittable disease in the world without a vaccine. More than 3 million Americans and around 180 million people from around the world suffer from chronic Hepatitis C. The virus spreads through contact … [Read more...]
WHO: 200,000 Ebola Vaccine Doses Available by Mid-2015
The World Health Organization speeds up the efforts to contain the Ebola outbreak in West Africa. During a press conference, Dr Marie Paule Kieny, a WHO assistant director-general, said they expect several hundred thousand vaccines to be ready by mid-2015. Kieny said that "While we hope that the massive response, which has been put in place will have an impact on the epidemic, it is still … [Read more...]
GlaxoSmithKline halts deliveries of two chickenpox vaccines
The drugmaker giant GlaxoSmithKline has halted the worldwide deliveries of two variant of chickenpox vaccines given to children after they failed to pass the quality tests. According to the company sources, some batches of the vaccines that were produced at its factory in Wavre, Belgium, were found to be sub-standard. This forced the company to disrupt its supply. Priorix-Tetra also called … [Read more...]
EMA gives nod to GlaxoSmithKline’s diabetes drug Eperzan, final decision soon
The European Medicines Agency (EMA) has green a green signal to GlaxoSmithKline for its once-weekly diabetes drug albiglutide. The Committee for Medicinal Products for Human Use (CHMP) of has recommended in a positive way to the drug which is marketed under the brand name Eperzan. Albiglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is an investigational biological product that … [Read more...]
GSK wins FDA approval for Mekinist-Tafinlar combination to treat melanoma
GlaxoSmithKline (GSK) has got green light from the Food and Drug Administration (FDA) for using a drug combination to treat melanoma, the deadliest form of skin cancer. The US regulator has approved GSK for the combined use of Tafinlar, also known as dabrafenib, and Mekinist, or trametinib for melanoma medication. The FDA approval was announced late on Wednesday. It is noteworthy that the … [Read more...]